APA (7th ed.) Citation

Hahn, A., Thiemer, R., Ludolph, A. C., Schwartz, O., Trollmann, R., Weydt, P., . . . Hagenacker, T. (2022). Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany. Orphanet journal of rare diseases, 17, . https://doi.org/10.1186/s13023-022-02420-8

Chicago Style (17th ed.) Citation

Hahn, Andreas, et al. "Short-term Safety Results from Compassionate Use of Risdiplam in Patients with Spinal Muscular Atrophy in Germany." Orphanet Journal of Rare Diseases 17 (2022). https://doi.org/10.1186/s13023-022-02420-8.

MLA (9th ed.) Citation

Hahn, Andreas, et al. "Short-term Safety Results from Compassionate Use of Risdiplam in Patients with Spinal Muscular Atrophy in Germany." Orphanet Journal of Rare Diseases, vol. 17, 2022, https://doi.org/10.1186/s13023-022-02420-8.